Brazil Pulse Oximeter Market Size & Outlook, 2023-2030

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pulse oximeter market will help companies and investors design strategic landscapes.

Monitors was the largest segment with a revenue share of 63.8% in 2023. Horizon Databook has segmented the Brazil pulse oximeter market based on monitors, sensors covering the revenue growth of each sub-segment from 2018 to 2030.

Brazil has a considerable prevalence of COPD, with about 15% of the population suffering from it. In addition, prevalence of cardiac disorders, such as cardiac arrhythmia, cardiac failure, hypertension, and ischemic heart disease, is increasing. This offers significant potential for growth of respiratory care and monitoring devices in this country. Organizations such as Brazilian Society of Newborn Screening are undertaking efforts to standardize newborn screening parameters in the country. The newborn screening program was initiated in 1976, however, it has not been implemented strictly and has covered only 55% of births and unevenly distributed across areas. 

In 2001, Newborn Screening National Programme (NSNP) was enforced by federal law. The improving scenario of newborn screening is anticipated to fuel the demand for pulse oximeters over the forecast period. Economic development in the country is also anticipated to boost the market. In 2013, Opto Circuits India (OCI) announced that its U.S.-based marketing subsidiary—Mediaid, Inc.— received approval from ANVISA for its pulse oximeter models: M960, M34, M30, and M900. Overall, Brazil is one of the biggest medical devices market in Latin America, and thus, establishing a market in Brazil would also enable retailing products in neighboring countries. 

All products, imported or manufactured and distributed in Brazil, must be registered with ANVISA. ANVISA is the autonomous regulatory body responsible for all medical devices marketed and sold in Brazil. Local manufacturers in Brazil can apply directly for registration through ANVISA, whereas all foreign manufacturers are required to appoint local third-parties called Brazilian Registration Holders (BRHs) for the same. In case of changing a BRH, reapplication for registration is required by the new holder.